The Transcorneal Penetration of Commercial Ophthalmic Formulations Containing Timolol Maleate in Rabbit Eyes
Authors:
- 10 October 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 31 (1) , 57-60
Abstract
Purpose: We investigated the transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes. Methods: One drop (30 μL) of each ophthalmic solution (Xalacom ® , DuoTrav ® , Cosopt ® , and Timoptol ® ) was administered to the conjunctival sac of the rabbits' eyes and the timolol maleate aqueous humor concentration was measured by high-performance liquid chromatography 15, 60, 120, and 240 min after the completion of administration. The effect of timolol ophthalmic solution pH (5.7–6.8) on ocular penetration was also examined. Results: The concentration [Cmax (μg/mL)] of timolol maleate, found in each of the 4 ophthalmic solutions, penetrated to the aqueous humor was as follows: DuoTrav>Cosopt>Timoptol>Xalacom. The concentration of timolol maleate penetrated to the aqueous humor was highest with solutions in the vicinity of pH 6.8. Conclusions: The concentration of timolol maleate penetrated to the aqueous humor was highest in DuoTrav followed by Cosopt, Timoptol, and Xalacom, and the pH and Benzalkonium chloride (BAK) concentration of the ophthalmic solution were believed to be factors that influenced this phenomena.Keywords
This publication has 14 references indexed in Scilit:
- Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulationsClinical Ophthalmology, 2013
- Quantitative evaluation of corneal epithelial injury caused by n-heptanol using a corneal resistance measuring device in vivoClinical Ophthalmology, 2012
- Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutionsCurrent Medical Research and Opinion, 2008
- The Effect of the Corneal Epithelium on the Intraocular Penetration of Fluoroquinolone Ophthalmic SolutionJapanese Journal of Ophthalmology, 2004
- Comparison of the Short-Term Effects on the Human Corneal Surface of Topical Timolol Maleate With and Without Benzalkonium ChlorideJournal of Glaucoma, 2003
- Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0.12% unoprostoneBritish Journal of Ophthalmology, 2000
- Effect of Beta-Blocker Eyedrops on Corneal Epithelial Barrier FunctionOphthalmologica, 2000
- Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cellsCurrent Eye Research, 2000
- Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucomaGraefe's Archive for Clinical and Experimental Ophthalmology, 1994
- Rate Limiting Barrier to the Penetration of Ocular Hypotensive Beta Blockers Across the Corneal Epithelium in the Pigmented RabbitJournal of Ocular Pharmacology and Therapeutics, 1990